Search
25/03/2025
Inositol 1,4,5-Trisphosphate Receptor 1 Gain-of-Function Increases the Risk for Cardiac Arrhythmias in Mice and Humans
Sun, B, Ni, MK, Li, YH, Song, ZP, Wang, H, Zhu, HL, Wei, JH, Belke, D, Cai, ST, Guo, WT, Yao, JJ, Tian, SS, Estillore, JP, Wang, RW, Sondergaard, MT, Brohus, M, Rohde, PD, Mu, YX, Vallmitjana, A, Benitez, R, Hove-Madsen, L, Overgaard, MT, Fishman, GI, Chen, J, Sanatani, S, Wilde, AAM, Fill, M, Ramos-Franco, J, Nyegaard, M, Chen, SRW. Inositol 1,4,5-Trisphosphate Receptor 1 Gain-of-Function Increases the Risk for Cardiac Arrhythmias in Mice and Humans. CIRCULATION. 2025; 151(12)DOI:10.1161/CIRCULATIONAHA.124.070563. PMID:39655431. IF:38.600(Q1/1D).
25/03/2025
Decreased practice effects in cognitively unimpaired amyloid betapositive individuals: a multicenter, longitudinal, cohort study
Tort-Merino, A, Pérez-Millan, A, Falgàs, N, Borrego-ecija, S, Esteller, D, Bosch, B, Castellví, M, Juncà-Parella, J, del Val-Guardiola, A, Fernández-Villullas, G, Antonell, A, Sanchez-Saudinós, MB, Rubio-Guerra, S, Zhu, NL, García-Martínez, M, Pozueta, A, Estanga, A, Ecay-Torres, M, de Luis, CL, Tainta, M, Altuna, M, Rodríguez-Rodríguez, E, Sánchez-Juan, P, Martínez-Lage, P, Lleó, A, Fortea, J, Illán-Gala, I, Balasa, M, Lladó, A, Rami, L, Sánchez-Valle, R. Decreased practice effects in cognitively unimpaired amyloid betapositive individuals: a multicenter, longitudinal, cohort study. ALZHEIMERS & DEMENTIA. 2025; 21(3)DOI:10.1002/alz.70016. PMID:40133248. IF:11.100(Q1/1D).
24/03/2025
Potential of facial biomarkers for Alzheimer's disease and obstructive sleep apnea in Down syndrome and general population
Echeverry-Quiceno, LM, Llambrich, S, Heredia-Lidón, A, Giménez, S, Rozalem-Aranha, M, Inampudi, P, Heuzé, Y, Sevillano, X, Fortea, J, Martinez-Abadias, N, Alzheimers Dis Neuroimaging Initiative. Potential of facial biomarkers for Alzheimer's disease and obstructive sleep apnea in Down syndrome and general population. FASEB JOURNAL. 2025; 39(6)DOI:10.1096/fj.202403009R. PMID:40123509. IF:4.200(Q1/2D).
22/03/2025
SSX and SS18-SSX Antibodies as Additional Tools for Diagnosing Undifferentiated Neoplasms With the EWSR1::SSX3 Fusion
Machado, I, Llombart-Bosch, A, Fumagalli, C, Antonescu, CR. SSX and SS18-SSX Antibodies as Additional Tools for Diagnosing Undifferentiated Neoplasms With the EWSR1::SSX3 Fusion. GENES CHROMOSOMES & CANCER. 2025; 64(3)DOI:10.1002/gcc.70044. PMID:40119747. IF:2.800(Q2/5D).
21/03/2025
Prevalence, diagnostic accuracy, and healthcare utilization patterns in patients with COPD in primary healthcare: a population-based study
Vila, M, Sisó-Almirall, A, Ocaña, A, Agustí, A, Faner, R, Borras-Santos, A, González-de Paz, L. Prevalence, diagnostic accuracy, and healthcare utilization patterns in patients with COPD in primary healthcare: a population-based study. npj Primary Care Respiratory Medicine. 2025; 35(1)DOI:10.1038/s41533-025-00419-9. PMID:40118910. IF:4.700(Q1/1D).
21/03/2025
Machine learning allows robust classification of lung neoplasm tissue using an electronic biopsy through minimally-invasive electrical impedance spectroscopy
Company-Se, G, Pajares, V, Rafecas-Codern, A, Riu, PJ, Rosell-Ferrer, J, Bragós, R, Nescolarde, L. Machine learning allows robust classification of lung neoplasm tissue using an electronic biopsy through minimally-invasive electrical impedance spectroscopy. Scientific Reports. 2025; 15(1)DOI:10.1038/s41598-025-94826-0. PMID:40119130. IF:3.900(Q1/2D).
21/03/2025
Allo-HCT refined ELN 2022 risk classification: validation of the Adverse-Plus risk group in AML patients undergoing allogeneic hematopoietic cell transplantation within the Spanish Group for Hematopoietic Cell Transplantation (GETH-TC)
Jiménez-Vicente, C, Esteve, J, Baile-González, M, Pérez-López, E, Calvo, CM, Aparicio, C, Ormategi, IO, Esquirol, A, Peña-Muñoz, F, Fernandez-Luis, S, Fernando, IH, González-Rodríguez, AP, López-García, A, López-Lorenzo, JL, Torrado, T, Marín, AJS, Fleytas, CA, García, L, Villar, S, Filaferro, S, Balsalobre, P, Cascón, MJP, Salas, MQ. Allo-HCT refined ELN 2022 risk classification: validation of the Adverse-Plus risk group in AML patients undergoing allogeneic hematopoietic cell transplantation within the Spanish Group for Hematopoietic Cell Transplantation (GETH-TC). Blood Cancer Journal. 2025; 15(1)DOI:10.1038/s41408-025-01223-x. PMID:40118819. IF:11.600(Q1/1D).
20/03/2025
When should the nephrologist think about genetics in patients with glomerular diseases?
Torra, R, Barros, X, Díaz-Encarnación, M, Fayos, L, Furlano, M, Pilco, M, Pybus, M, Shabaka, A, Viera, E, Ars, E. When should the nephrologist think about genetics in patients with glomerular diseases?. Clinical Kidney Journal. 2025; 18(3)DOI:10.1093/ckj/sfaf044. PMID:40115110. IF:4.600(Q1/2D).